News
Leeds academics find inadequate support for sexual dysfunction in prostate cancer patients
More than 4 in 5 men (81%) with prostate cancer struggle with poor sexual function following treatment for the disease, but over half (56%) fail to receive support, according to new research.
Research grant will aid in understanding microbiomes' roles in bowel cancers
Professor Philip Quirke, from the Leeds Institute for Medical Research at St James’s, has been awarded nearly £2.5 million from Cancer Research UK, as part of their new Grand Challenge funding.
Leeds academic wins scientific prize
Congratulations to Dr Kate Marks, Academic Clinical Fellow
Could cancer anti-sickness drug end the misery for IBS patients?
Could a commonly-prescribed anti-sickness drug be the answer for the 1.3 million people in the UK who suffer the pain and misery of irritable bowel syndrome with diarrhoea (IBS-D)?
Low-cost drugs provide hope for bowel cancer prevention
Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research.